Have you experienced negative side effects from the osteoporosis drug Reclast? Bisphosphonate medications like Reclast have been linked to unusual femur fractures, bone diseases and other serious side effects. If you took Reclast for an extended period of time and suffered from a femur fracture or other bone injury, please contact the Reclast lawyers at Schmidt & Clark, LLP for a free case evaluation.
Reclast Update 6/28/12: In a new web guide published by the FDA, the administration lays out new guidance for the use of bisphosphonates, tentatively recommending a three to five year time limit for the drugs, at least until more conclusive data becomes available. The five-year time limit was originally suggested in a September 2011 report issued by the FDA, which concluded that there appears to be no tangible benefit to extending bisphosphonate regimens beyond five years. Click here to learn more.
Reclast Bone Fracture Update 5/24/12: In a study published this week by the Archives of Internal Medicine, Swiss researchers reached conclusions similar to those reached earlier this month by the U.S. Food & Drug Administration (FDA) – that taking osteoporosis drugs from the bisphosphonate class can increase the risk of atypical bone fractures. Taken cumulatively, the results of the study seem to suggest that the risk of fractures increased over time while the benefits of the drugs decreased. Click here to learn more.
Free Reclast Case Evaluation: If you or a loved one has sustained an injury you feel may have been caused by Reclast, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.
Reclast Kidney Failure Update 9/1/11: According to the U.S. Food & Drug Administration (FDA), Reclast has been linked to severe kidney impairment and acute renal failure. The administration has issued a Drug Safety Communication stating that it is requiring Reclast warning labels to be updated to include information about this risk. Click here to learn more.
What’s the problem?
Marketed and manufactured by Novartis A.G., Reclast (zoledronic acid) is a prescription bisphosphonate medication used in the treatment of osteoporosis, hypocalcemia, and certain types of cancer. What sets Reclast apart from the majority of other osteoporosis drugs is that it is designed to be administered just once a year via intravenous infusion, which some patients prefer to monthly or weekly administration. Unfortunately, Reclast has been linked to femur and hip fractures, as well as a serious bone disease called osteonecrosis of the jaw (ONJ). In October 2010, the U.S. Food & Drug Administration (FDA) announced that it was updating patient information to include warnings about the risk of atypical fractures of the thigh in individuals taking bisphosphonate medications like Reclast.
Side Effects of Reclast
There are a variety of side effects associated with Reclast. Our firm is pursing the following types of severe side effects:
- Osteonecrosis of the Jaw (Dead Jaw)
- Atypical femur fractures
- Swelling or infection of the gums
- Loosening of the teeth
- Poor healing of the gums
- Numbness or a feeling of heaviness in the jaw
- Exposed bone
- Hip Fractures
- Renal failure
Which Bisphosphonate Drugs have been linked to these side effects?
In addition to Reclast, bisphosphonate drugs that carry an increased risk of these side effects include:
Reclast Hip Fracture Lawsuits
There have been numerous Reclast lawsuits brought against Novartis on behalf of patients who have developed hip fractures after taking the medication for an extended period of time (usually five years or longer). Especially troubling is the fact that these fractures are not just occurring in elderly individuals, but in younger patients as well. Younger women on hormone replacement therapy have been known to take Reclast for longer periods of time than post-menopausal women.
Do I have a Reclast Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Reclast lawsuits. We are handling individual litigation nationwide and currently accepting new bone injury cases in all 50 states.